New Horizon Health

New Horizon Health R&D per Employee

Delisted·Feb 9, 2026

The R&D Spending per Employee of New Horizon Health (6606.HK) as of Oct 29, 2026 is 105,019.43 CNY. In the previous year, R&D Spending per Employee was 65,390.70 CNY — a change of 60.60% (higher).

R&D per Employee

105,019.43CNY

YoY

60.60%

Last updated:

R&D Spending per Employee of New Horizon Health is 2022 105,019.43 CNY. R&D Spending per Employee of New Horizon Health was 2021 65,390.70 CNY. It decreases by 60.60% higher compared to the previous year.

The New Horizon Health R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2018
16,406.79 CNY
Jan 1, 2019
29,275.56 CNY
Jan 1, 2020
28,125.45 CNY
Jan 1, 2021
65,390.70 CNY
Jan 1, 2022
105,019.43 CNY
The New Horizon Health R&D per Employee history
YEARR&D per EmployeeYoY
105,019.43CNY+60.60%
65,390.70CNY+132.50%
28,125.45CNY-3.93%
29,275.56CNY+78.44%
16,406.79CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

New Horizon Health Stock analysis

What does New Horizon Health do? New Horizon Health Ltd. generates revenue through the distribution of its ColoClear and Pupu tube products via its own network, contracted sales organisations (CSOs), and e-platforms managed by healthcare clinics. The company also develops Youyou Tube, a stool-based self-checking gastric cancer screening test, and CerviClear, a non-invasive urine cervical cancer home screening test, which are currently under development. Its primary customers include healthcare clinics and end-users seeking non-invasive cancer screening solutions. The firm's product portfolio focuses on innovative medical screening tools, targeting the growing demand for accessible and user-friendly health diagnostics. By leveraging its internal sales channels and partnerships with CSOs, New Horizon Health Ltd. ensures broad market reach for its products. The company's development of Youyou Tube and CerviClear reflects its strategic emphasis on expanding into high-need areas of cancer prevention and early detection. Revenue streams are derived from the sale of ColoClear and Pupu tube products, with future potential from the commercialization of Youyou Tube and CerviClear once development is complete. The company's business model relies on direct and indirect sales channels to healthcare providers and consumers, positioning it within the medical diagnostics sector. New Horizon Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about New Horizon Health stock

R&D Spending per Employee of New Horizon Health is 105,019.43 CNY in 2022.

R&D Spending per Employee of New Horizon Health changed from 65,390.70 CNY to 105,019.43 CNY, representing a 60.60% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee New Horizon Health since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's New Horizon Health historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — New Horizon Health

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — New Horizon Health